Literature DB >> 26255571

Assessment of muscle tissue oxygen saturation after out-of-hospital cardiac arrest.

Jean-Christophe Orban1, Audrey Scarlatti2, Pierre-Eric Danin3, Jean Dellamonica3, Gilles Bernardin3, Carole Ichai2.   

Abstract

PURPOSE: Pathophysiology of cardiac arrest corresponds to an ischemia-reperfusion syndrome with deep impairment of microcirculation. Muscular tissue oxygen saturation (StO2) is a noninvasive method of evaluation of microcirculation. Our study was aimed at assessing the prognosis value of muscular StO2 in patients admitted for out-of-hospital cardiac arrest (OHCA) and treated with hypothermia.
MATERIALS AND METHODS: We conducted a prospective bicentric observational study including OHCA patients treated with therapeutic hypothermia. Baseline StO2, derived variables (desaturation and resaturation slopes), and lactate levels were compared at different times between patients with good and poor outcomes. Prognosis was assessed by the Cerebral Performance Category (CPC) score at 6 months after admission (CPC 1-2, good outcome; CPC 3-5, poor outcome).
RESULTS: Forty-four patients were included, 17 good and 27 poor outcomes at 6 months. At admission, StO2 and lactate levels were lower in good outcome patients. Desaturation and resaturation slopes did not differ between groups.
CONCLUSIONS: After an OHCA treated with therapeutic hypothermia, StO2 was correlated with outcome. Further research is needed to better understand the pathophysiological process underlying our results.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Out-of-hospital cardiac arrest; Outcome; Tissular saturation of oxygen

Mesh:

Substances:

Year:  2015        PMID: 26255571     DOI: 10.1016/j.jcrc.2015.07.010

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  1 in total

1.  Therapeutic Hypothermia Reduces Oxidative Damage and Alters Antioxidant Defenses after Cardiac Arrest.

Authors:  Fernanda S Hackenhaar; Tássia M Medeiros; Fernanda M Heemann; Camile S Behling; Jordana S Putti; Camila D Mahl; Cleber Verona; Ana Carolina A da Silva; Maria C Guerra; Carlos A S Gonçalves; Vanessa M Oliveira; Diego F M Riveiro; Silvia R R Vieira; Mara S Benfato
Journal:  Oxid Med Cell Longev       Date:  2017-05-01       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.